These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6858559)

  • 1. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
    Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute liver failure by diphenylhydantoin].
    Bosia JD; Borzi S; Cocozzella D; Corallini O; Mayet M; Malca M; Padrone M; Rivero A; Cecchi G; Fraquelli E; Curciarello JO
    Acta Gastroenterol Latinoam; 2000; 30(2):73-6. PubMed ID: 10925722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 5. Mononucleosis and hepatic failure associated with diphenylhydantoin treatment in an infant.
    Ni YH; Chang MH; Wu MZ
    J Formos Med Assoc; 1991 Feb; 90(2):202-5. PubMed ID: 1678417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylhydantoin-induced pure red cell aplasia.
    Rusia U; Malhotra P; Joshi P
    J Indian Med Assoc; 2006 Jan; 104(1):34-6. PubMed ID: 16850864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy].
    Kanoh T; Dobashi H; Inada T
    Rinsho Ketsueki; 1996 Mar; 37(3):239-43. PubMed ID: 8727349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolated increased of blood alkaline phosphatases, induced by diphenylhydantoin. Clinical interest].
    Gil González I
    An Med Interna; 1995 Aug; 12(8):409-10. PubMed ID: 8924537
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between some anticonvulsants and tumors of the blood forming organs.
    Bercel NA; Henstell HH
    Bull Los Angeles Neurol Soc; 1970 Jan; 35(1):21-4. PubMed ID: 5411538
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and experimental studies on folic acid deficiency due to anticonvulsants. 2. Investigations on patients receiving anticonvulsants and experimental study on the effect of diphenylhydantoin on the absorption of folic acid in rats.
    Taguchi H
    Acta Med Okayama (1952); 1971 Oct; 25(5):551-66. PubMed ID: 4264433
    [No Abstract]   [Full Text] [Related]  

  • 13. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Mononucleosis-like" caused by carbamazepine].
    Navarro Fontanellas E; Prat Rojo J
    Aten Primaria; 2000 Mar; 25(4):284-5. PubMed ID: 10795448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].
    Pereira A; Cervantes F; Rozman C
    Med Clin (Barc); 1985 Oct; 85(12):503-5. PubMed ID: 4079508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenytoin neurotoxicity].
    Rodríguez Gaspar MA; Martínez Riera A; González Reimers E; Santolaria Fernández F
    An Med Interna; 2000 Nov; 17(11):619-20. PubMed ID: 11322044
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus-associated mononucleosis caused by weekly low-dose methotrexate therapy in a rheumatoid arthritis patient.
    Shoda H; Nakazaki K; Izutsu K; Tanaka R; Komagata Y; Misaki Y; Yamamoto K
    Scand J Rheumatol; 2006; 35(2):152-3. PubMed ID: 16641052
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenytoin hypersensitivity syndrome.
    Sanders DY; Thompson JR; Carlton FB
    J Miss State Med Assoc; 1996 Feb; 37(2):471-5. PubMed ID: 9053530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute hepatic cell damage by simultaneous administration of isonicotinic acid hydrazide and antiepileptic agents in humans, (diphenylhydantoin or carbamazepin)].
    Dold U; Reichenmiller HE
    Med Welt; 1969 Jan; 1():48-54. PubMed ID: 5775507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diphenylhydantoin-induced pure red cell aplasia after neurological surgery: report of two cases].
    Tanaka S; Toujou H; Tara M; Uetsuhara K
    No Shinkei Geka; 2000 Aug; 28(8):713-7. PubMed ID: 11002494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.